## Clinical Presentation & Diagnosis This patient presents with a **clinically isolated syndrome (CIS)** — specifically optic neuritis — which is a demyelinating event. The presence of oligoclonal bands in CSF and the imaging findings are consistent with **multiple sclerosis (MS)**. ## MRI Findings in Demyelinating Optic Neuritis **Key Point:** Gadolinium enhancement in acute demyelinating optic neuritis indicates active inflammation with **blood-brain barrier (BBB) disruption**. This is a hallmark of acute demyelinating disease. ### Enhancement Patterns | Feature | Acute Demyelination | Chronic/Resolved | |---------|-------------------|------------------| | **Gadolinium enhancement** | Present (BBB disruption) | Absent | | **T2 signal** | Hyperintense | May persist | | **Clinical correlation** | Active inflammation | Residual damage | | **Prognosis** | Reversible with treatment | Fixed deficit | **High-Yield:** Gadolinium enhancement = **active inflammation**, not severity. It indicates the lesion is recent (days to weeks old) and the BBB is compromised. ## Why This Is MS, Not Other Demyelinating Diseases 1. **Oligoclonal bands in CSF** — highly specific for MS (present in ~95% of MS patients) 2. **Optic neuritis as CIS** — 50% of patients with optic neuritis will develop MS within 15 years 3. **Central nervous system involvement** — MS typically affects brain and spinal cord **Clinical Pearl:** The **Optic Neuritis Treatment Trial (ONTT)** showed that patients with optic neuritis who have abnormal brain MRI (≥3 T2 lesions) have a 50% risk of developing clinically definite MS within 15 years, rising to ~80% over 20 years. ## Differential Considerations **ADEM:** Typically presents with multifocal involvement, often follows viral infection, and usually occurs in children/young adults with rapid progression. CSF oligoclonal bands are less common. **NMOSD:** Characterized by **longitudinally extensive transverse myelitis (LETM)** and optic neuritis, but optic nerve enhancement is NOT pathognomonic — it occurs in MS as well. NMOSD is distinguished by aquaporin-4 (AQP4) antibodies and specific spinal cord involvement patterns. **Leber Hereditary Optic Neuropathy:** A mitochondrial disorder causing painless, progressive vision loss without enhancement on MRI. No inflammatory features. [cite:Harrison 21e Ch 380] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.